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Abstract: A clinic- based intervention study was conducted among high- risk human papil-
lomavirus (HPV)- infected Latinas aged 18-64 years between April 2006 and May 2008 on 
the Texas- Mexico border. Women were randomly assigned to receive a printed material 
intervention (n=186) or usual care (n=187) and were followed at three months, six months, 
and 12 months through telephone surveys and review of medical records. The HPV knowl-
edge of nearly all women had increased greatly, but only two- thirds of women reported 
they had received follow-up care within one year of diagnosis regardless of additional 
health education messaging. Our findings suggest that, regardless of type of health educa-
tion messaging, Latinas living on the Texas- Mexico border are aware that follow-up care 
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is recommended, but they may not receive this care. Individual, familial and medical care 
barriers to receipt of follow-up care may partially account for the higher rates of cervical 
cancer mortality in this region.
Key words: Follow-up care, HPV, Latina, intervention study.
Persistent infection with two high- risk types of human papillomavirus (HPV- 16 and/or HPV- 18) is known to cause 70% of cervical cancers.1 Despite increases in 
cervical cancer screening in the past few decades, Latinas have substantially higher rates 
of cervical cancer mortality than non- Hispanic White women.2 Although a vaccine to 
protect against these high- risk HPV types was released in 2006, it is not available to 
older women and cervical cancer screening is still recommended for women who receive 
the vaccine.3 The decline in cervical cancer mortality rates seen since the 1950s that was 
attributed to increased cervical cancer screening has leveled off and was stable from 
2007 to 2011.4 Latinas continue to experience higher rates of cervical cancer mortality 
than non- Hispanic Whites due to lower rates of cervical cancer screening and poor 
adherence to follow-up care after abnormal Pap tests.5 As many as 80% of cervical 
cancer deaths could be averted through appropriate screening and follow-up care.6
From 1997– 2006, Latinas living on the Texas border had a 31% higher cervical can-
cer mortality rate than non- border Latinas in Texas.7 A possible explanation for this 
disparity is the failure of border Latinas to receive Pap tests8 or to receive appropriate 
follow-up care after abnormal Pap tests.9
The objective of the present study was to evaluate the effect of a health messaging 
intervention on receipt of follow-up care among high- risk HPV infected Latinas living 
on the Texas- Mexico border. Follow-up care was based on women’s reports of their 
health care providers’ recommendations at baseline for follow-up diagnostic procedures, 
treatments and recommendations. Latinas newly diagnosed with high- risk HPV were 
randomized to receive a printed health education material intervention in the form 
of an HPV educational brochure developed by the Centers for Disease Control and 
Prevention (CDC). We hypothesized that Latinas who received the HPV brochure 
would have 1) increased knowledge of HPV, and 2) more timely receipt of follow-up 
care after a high- risk HPV diagnosis than Latinas randomized to receive usual care.
Methods
Conceptual framework. Our conceptual framework was based on a combination of 
health behavior theories and constructs such as the Theory of Planned Behavior,10– 12 the 
Health Belief Model,10 and self- efficacy.11– 12 Certain attitudes and perceptions influence 
behavioral intention, and ultimately the behavior of interest. The model shows how the 
woman, provider, and environmental factors interact.
Study design. We conducted a clinic- based intervention study to examine a health 
education message intervention between April 2006 and May 2008. Inclusion criteria 
were: Latinas aged 18– 64 years living on the Texas- Mexico border who were diagnosed 
with high- risk HPV through Hybrid Capture 2 with no history of treatment for an 
abnormal Pap test. Clinic providers identified women shortly after diagnosis and prior 
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to treatment. The majority of participants were recruited from the dysplasia clinic that 
provided diagnosis and treatment for women participating in the Texas Breast and Cer-
vical Cancer Screening Program. A total of 460 women were recruited and interviewed 
in the clinic shortly after their HPV diagnosis had been explained to them by their 
provider (88.8% response rate) (Supplementary Table 1). After the baseline survey, all 
women had the opportunity to ask HPV questions, which interviewers were trained to 
answer using a list of responses developed by our study gynecologic oncologist (CDA); 
women were told to ask their providers questions that did not appear on the list. Of 
the 460 women completing the baseline survey, 130 women asked the interviewer a 
question (broken down by 71 in the intervention and 59 in the control group). Half of 
the women (n=186) were randomly selected to receive an eight- page CDC- developed 
HPV educational brochure level available in English and Spanish, and the other half 
of women (n=187) received usual care. The sample size required to detect a 0.15 rate 
difference at a 0.05 significance level with 80% power was 176 participants per group.
Detailed methods of the brochure development have appeared elsewhere.13 Briefly, 
in February 2005 two different brochures were tested with 15 focus groups of White, 
African American, and Hispanic individuals with less than a college education between 
ages 18 and 29, who were low- income and currently or planning to become sexually 
active. The focus groups were stratified by gender, race/ ethnicity, language and geography 
and the final brochure was geared toward an 8th grade reading level. The brochure 
covered the following topics: 1) Why haven’t more people heard of genital HPV? 2) How 
common is genital HPV? 3) Who gets genital HPV? 4) What makes a person more 
likely to get HPV? 5) What does “low- risk” HPV mean? 6) What does “high- risk” HPV 
mean? 6) Does “high- risk” HPV mean cancer? 7) How can women prevent cervical 
cancer? 8) Why should women get regular Pap tests? 9) Should women worry about 
abnormal Pap test results? 10) What about a HPV test for women? 11) What’s the dif-
Supplementary Table 1.
RESPONSE RATES TO QUANTITATIVE SURVEYSa
Baseline 
(n=518)
3‑month 
(n=460)
6‑month 
(n=460)
12‑month 
(n=460)
Response  n  %  n  %         
Refused 55 10.6 15 3.3 4 0.9 3 0.7
Lost to follow-up 3 0.6 36 7.8 24 5.2 43 9.3
Insufficient time — 44 9.6 102 22.2 198 43.0
Completed 460 88.8 365 79.3 330 71.7 216 47.0
a Of the 373 women included in the present analysis, 191 women completed 3 follow-up surveys 
(51.2%), 111 women completed 2 follow-up surveys (29.8%), and 71 women completed 1 follow-up 
survey (19.0%).
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ference between the Pap test and the HPV test? 12) Do I need to know if I have genital 
HPV? 13) Is there a cure for genital HPV? 14) Are there ways to reduce my chances of 
getting genital HPV? 15) What are condoms? 16) What about a vaccine? The content 
was similar to that of brochures produced by Krames, Planned Parenthood, American 
College of Obstetricians and Gynecologists, Merck, and county health departments. 
The present analysis is restricted to women who identified themselves as Latina who 
completed at least one follow-up survey (n=373).
Data gathered from our formative research were used to develop the baseline and 
follow-up patient surveys which covered HPV knowledge, reaction to an abnormal 
Pap or HPV diagnosis, and patient- provider communication. Our formative research 
consisted of in-depth personal interviews with 44 women recently diagnosed with 
a positive high- risk HPV test;14 focus groups with 30 women and 11 men on HPV 
knowledge, attitudes and beliefs;15 and in-depth telephone interviews with 26 women’s 
health care providers. Follow-up telephone surveys were designed to determine whether 
women had received follow-up care and to assess whether women retained information 
provided to them during their baseline survey. Medical records were also abstracted 
for information on receipt of follow-up care.
HPV knowledge, attitudes, and beliefs indices reported during baseline survey. 
Based on prior formative research, we developed an HPV knowledge index that was 
a summation of the total number of correct responses to 13 questions such as “Can 
human papillomavirus be spread by sex?” answered by women who indicated they 
had heard of HPV during the baseline survey. The 144 women who had not heard of 
HPV were assigned a 0. Two subscales (one consisting of nine items and one with six 
items) were used to assess HPV attitudes. For the nine- item subscale, participants who 
responded to questions such as “As a result of your abnormal Pap or HPV test results, 
how much do you feel stressed?” with “very much/ somewhat” were coded 0 and “just 
a little/ not at all” were coded 1. For the six- item subscale, participants who indicated 
they had told someone of their diagnosis and responded to questions such as “Most 
people have been supportive after hearing that you have HPV” with “strongly agree/ 
agree” were coded 1 and “undecided/ disagree/ strongly disagree” were coded 0. A total 
of 59 women who indicated they had not told anyone of their diagnosis were assigned 
a 0 for this subscale.
A 10-item HPV beliefs index was created in which participants who responded to 
questions such as “Having HPV makes me more aware of my health,” with “strongly 
agree/ agree” were coded 1 and “undecided/ disagree/ strongly disagree” were coded 
0. Scale items were reverse- coded as needed. The approximate median was used to 
dichotomize these indices as high or low since they were developed by our team and 
had not been validated.
Recommended follow‑up care reported during baseline survey. Women’s reports 
of their health care providers’ recommendations at baseline for follow-up diagnostic 
procedures, treatments and recommendations were in response to the question “Which 
one(s) of the following things did your health care provider tell you to do because of 
your abnormal Pap or HPV diagnosis?” We grouped the categories “Have a colposcopy/ 
 Have a test that takes a closer look at your cervix” and “Have a biopsy” as one diag-
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nostic procedure. The other diagnostic procedure was “Have another Pap smear.” The 
categories “Have cryotherapy (freezing)” and “Have some other kind of treatment 
(loop electrosurgical excision procedure [LEEP] or laser)” were grouped as treatment. 
Women who responded “Other” and specified the other recommendation were recoded 
into appropriate categories.
Knowledge of HPV and receipt of follow‑up care reported during follow‑up sur‑
vey. Knowledge of HPV at follow-up was based on the HPV knowledge index detailed 
previously and answered by all women. Women who correctly answered any of the 
13 items during a particular follow-up survey were given credit for a correct response 
for that survey only. Receipt of follow-up care was based on women’s self- report of 
diagnostic procedures or cryotherapy/ other treatment in response to the question, 
“Which of the following things have you done since the last time we talked because 
of your HPV diagnosis?” Women who responded that they had received diagnostic 
procedures or cryotherapy/ other treatment during any of the follow-up surveys were 
considered as having received follow-up care overall.
Statistical analysis. The statistical analysis for this paper was generated using SAS 9.2 
software (Copyright, SAS Institute Inc. SAS and all other SAS Institute Inc. product 
or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, 
NC, USA). Chi- square was used to compare the baseline demographic and HPV char-
acteristics of women randomized to receive the HPV brochure or usual care to assess 
the success of our randomization. Chi- square was also used to characterize the patient 
recall of recommended follow-up care reported at baseline by type of intervention. We 
used generalized estimating equations (GEE) to estimate the rate ratios (RR) for type 
of health education messaging received at baseline and self- reported knowledge of 
HPV and receipt of follow-up care while accounting for repeated measures over time.16 
Women with nine or more (70% or higher) correct responses to the HPV knowledge 
index on any follow-up survey were considered to have adequate HPV knowledge. 
Women who reported they received follow-up diagnostic procedures and/or treatment 
on any follow-up survey were categorized accordingly.
Results
Table 1 presents the baseline demographic characteristics of Latinas who received the 
brochure intervention versus usual care. Women in both arms of the trial were com-
parable in age, birthplace, amount of time lived in the United States, language used 
to complete the survey, educational level, and health insurance coverage. Nearly half 
of women in both groups were self- pay. Women randomized to receive the brochure 
intervention were significantly less likely to be married than women who received 
usual care (p=.03).
Table 2 presents HPV awareness, HPV vaccine awareness, and HPV knowledge, 
attitudes and beliefs reported at baseline. Just over 60% of women had heard of HPV 
or the HPV vaccine, and there was no difference in women who received the brochure 
intervention compared with women who received usual care. Similarly, there were low 
HPV knowledge, attitudes and beliefs overall, which did not differ between women who 
received the brochure intervention compared with women who received usual care.
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Table 1.
DEMOGRAPHIC CHARACTERISTICS OF LATINAS WHO 
RECEIVED THE BROCHURE INTERVENTION VERSUS USUAL 
CARE REPORTED DURING BASELINE SURVEY
Brochure 
intervention 
(n=186)
Usual care 
(n=187)
Demographic characteristic  n  %  n  %  p‑ value
Age (years)
 18– 24 72 38.7 72 38.5 .96
 25– 34 74 39.8 78 41.7
 35– 44 28 15.1 27 14.4
 45– 64 12 6.5 10 5.4
Birthplace
 United States 81 43.6 85 45.5 .71
 Mexico 105 56.4 102 54.6
Amount of time in United States (years)
 <2 10 10.2 6 5.8 .62
 2– 5 18 17.4 26 25.2
 6– 10 23 22.5 21 20.4
 11– 15 25 23.5 24 23.3
 16– 20 15 15.3 12 11.7
 >20 12 11.2 14 13.6
 Missing 4 2
Language used to complete survey
 English 91 48.9 85 45.5 .50
 Spanish 95 51.1 102 54.6
Marital status
 Unmarried 72 38.7 49 26.2 .03
 Married/ living with a partner 84 45.2 95 50.8
 Divorced/ widowed/ separated 30 16.1 43 23.0
Educational level
 Less than high school 92 49.5 81 43.3 .42
 High school graduate 56 30.1 59 31.6
 More than high school 38 20.4 47 25.1
Health insurance coverage
 Private insurance 8 4.7 13 7.8 .48
 Medicaid 78 45.4 73 44.0
 Self- pay 86 50.0 80 48.2
 Missing  14    21     
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Table 3 presents patient recall of follow-up diagnostic procedures, treatment, and 
recommendations reported at baseline by receipt of the brochure intervention versus 
usual care. High percentages of women reported they were told to undergo follow-up 
diagnostic procedures (96.3% for colposcopy/ biopsy, 87.1% for repeat Pap test) which 
did not differ by receipt of the brochure intervention or usual care. Only one- fourth of 
women (25.8%) indicated they were told to undergo cryotherapy/ other treatment and 
a very small percentage of women reported they were told to “use a medicine to get 
rid of warts on the outside of your vagina” (9.3%) with neither differing by receipt of 
the brochure intervention or usual care. The proportions of women reporting specific 
recommendations ranged from 57% for “stop having sex” to 69% for “don’t douche.” 
The percentage of women indicating they were told to “tell your partner that you have 
HPV” was significantly lower among women who received the brochure intervention 
(58.1%) than among women who received usual care (76.2%) (p=.0002). Although 
the difference was not significant, a lower percentage of the women who received the 
brochure intervention than who received usual care indicated they were told at baseline 
to “use condoms every time you have sex.”
Table 2.
CHARACTERISTICS REGARDING HPV AMONG LATINAS WHO 
RECEIVED THE BROCHURE INTERVENTION VERSUS USUAL 
CARE REPORTED DURING BASELINE SURVEY
Brochure 
intervention 
(n=186)
Usual care 
(n=187)
Characteristics of HPV  n  %  n  %  p‑ value
Heard about HPV
 No 79 42.5 65 34.8 .13
 Yes 107 57.5 122 65.2
Heard about HPV vaccine
 No 81 43.5 68 36.4 .16
 Yes 105 56.5 119 63.6
HPV knowledge index
 0– 8 95 51.1 90 48.1 .57
 9– 13 91 48.9 97 51.9
HPV attitudes index
 0– 9 96 52.2 107 57.5 .30
 10– 15 88 47.8 79 42.5
 Missing 2 1
HPV beliefs index
 0– 6 109 58.6 94 50.5 .12
 7– 10 77 41.4 92 49.5
 Missing  0    1    
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Table 3.
PATIENT RECALL OF RECOMMENDED FOLLOW- UP CARE OF 
LATINAS WHO RECEIVED THE BROCHURE INTERVENTION 
VERSUS USUAL CARE REPORTED DURING BASELINE SURVEY
Brochure 
intervention 
(n=186)
Usual care 
(n=187)
Follow‑up care  n  %  n  %  p‑ value
Self- report of diagnostic procedures
 Colposcopy/ biopsy
  No 8 4.3 6 3.2 .58
  Yes 178 95.7 181 96.8
 Repeat Pap test
  No 24 12.9 24 12.8 .98
  Yes 162 87.1 163 87.2
Self- report of treatment
 Cryotherapy/ other treatment
  No 132 71.0 144 77.4 .16
  Yes 54 29.0 42 22.6
  Missing 0 1
 Treat warts
  No 167 90.8 164 90.6 .96
  Yes 17 9.2 17 9.4
  Missing 2 6
Self- report of recommendations
 Don’t douche
  No 57 31.0 55 30.0 .85
  Yes 127 69.0 128 70.0
  Missing 2 4
 Tell your partner you have HPV
  No 78 41.9 44 23.8 .0002
  Yes 108 58.1 141 76.2
  Missing 0 2
 Use condoms
  No 72 38.7 56 30.1 .08
  Yes 114 61.3 130 69.9
  Missing 0 1
 Don’t smoke
  No 82 44.6 70 37.4 .16
  Yes 102 55.6 117 62.6
  Missing 2 0
 Stop having sex
  No 83 44.9 76 40.9 .44
  Yes 102 55.1 110 59.1
  Missing  1    1     
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Table 4 presents the association between receipt of the brochure intervention 
versus usual care and self- reported knowledge of HPV and receipt of follow-up care 
reported at follow-up. Nearly all women had reported 9 or more correct responses to 
the HPV knowledge index during one or more follow-up surveys. Only two- thirds of 
women reported they had received follow-up care within one year of diagnosis. After 
adjustment for marital status, there was little effect of the brochure intervention on 
knowledge of HPV (RR 1.08, 95% CI 0.81– 1.45) or receipt of follow-up care (RR 0.95, 
95% CI 0.74– 1.23).
Discussion
Although the participants in our study had been diagnosed with high- risk HPV, at 
baseline almost 40% indicated they had not heard of HPV or the HPV vaccine, and had 
correspondingly low levels of HPV knowledge, attitudes and beliefs. In a study of 215 
HPV negative women we conducted from April 2007 to April 2008, similar percent-
ages reported they had not heard of HPV (39.1%) or the HPV vaccine (42.1%).17 This 
lack of HPV awareness has also been found among Latina immigrants in Birmingham, 
Alabama.18
The high proportion of women who had not heard of HPV or the HPV vaccine may 
Table 4.
KNOWLEDGE OF HPV AND RECEIPT OF FOLLOW- UP CARE 
OF LATINAS WHO RECEIVED THE BROCHURE INTERVENTION 
VERSUS USUAL CARE REPORTED DURING FOLLOW- UP 
SURVEY(S)
Brochure 
intervention 
(n=186)
Usual care 
(n=187)
Characteristic  n  %  n  %  RRa  95% CIb
HPV knowledge indexc
 Inadequate 7 3.8 9 4.8 1.00 referent
 Adequate 178 96.2 178 95.2 1.08 0.81– 1.45
 Missing 1 0
Follow-up care d
 No 60 32.4 59 31.7 1.00 referent
 Yes 125 67.6 127 68.3 0.95 0.74– 1.23
 Missing 1 1
aRate ratio adjusted for marital status.
bConfidence interval.
cAt least one follow-up survey with 9 or more correct responses to knowledge index.
dSelf- reported receipt of follow-up diagnostic procedures and/or treatment.
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have been due to ineffective provider- patient communication. Effective provider- patient 
communication is important in delivering challenging information. Talking with patients 
about how their own or their partners’ sex lives have increased their risk of cancer in 
this bilingual border population with traditional sex roles challenges providers and 
patients. To determine how providers communicated with their patients, we conducted 
in-depth provider interviews, which covered communication with women who have 
an abnormal Pap test/ high- risk HPV diagnosis, perception of patients’ reaction to an 
abnormal Pap test/ high- risk HPV diagnosis, perception of patients’ understanding of 
HPV, and HPV patient educational materials used with 26 providers of women’s health 
care (74.3% response rate). Most providers reported they informed female patients of 
their HPV status by telling them they had a “sexually transmitted infection that may 
cause cervical cancer.” Women may not hear the entire message after having a highly 
personal reaction to being told they have a sexually transmitted infection, and won-
der why they are returning for results of an abnormal Pap which might mean cancer. 
Starting the provision of this information with how common HPV is may ease the 
patients into the idea, allowing them to hear the accurate (yet alarming) information 
providers may give.
Nearly all participants reported they were told at baseline to receive follow-up care. 
Results from our in-depth provider interviews verified that the vast majority of providers 
recommended follow-up diagnostic procedures and treatments, and many providers also 
recommended their patients “practice safe sex, including condoms” and “stop smoking.” 
Although a majority of participants reported they were told “don’t douche” and “stop 
having sex,” no providers indicated they had recommended against douching or having 
sex. Of concern is the substantially lower percentage of participants who received the 
brochure intervention than usual care who reported they were not told to “tell your 
partner that you have HPV” or “use condoms every time you have sex.” The question 
of partner disclosure was not asked of providers specifically; however, it is inconceiv-
able that providers would not inform patients to tell their partners of their diagnosis. 
The possible confusion about provider recommendations was noted by some providers 
who “recognized challenges to effectively communicating with patients at their level.”
The percentage of patients whose HPV knowledge was classified as inadequate 
decreased from 49.6% at baseline to 4.3% at follow-up. The more surveys a participant 
completed the more likely she was to correctly respond to nine or more HPV knowl-
edge questions from our index. Of the 16 participants whose HPV knowledge was 
classified as inadequate at follow-up, one had completed three follow-up surveys, five 
had completed two follow-up surveys, and 10 had completed one follow-up survey. 
Thus, as has been seen in other studies,19 the act of completing a survey(s) served as 
an educational intervention with regard to HPV knowledge.
Only two- thirds of participants reported they had received follow-up care within one 
year of diagnosis. As was the case with HPV knowledge, the more surveys a participant 
completed the more likely she was to report having received follow-up care. Of the 373 
participants included in the present analysis, 191 completed three follow-up surveys 
(51.2%), 111 completed two follow-up surveys (29.8%), and 71 completed one follow-up 
survey (19.0%). Some participants who completed the three- month follow-up survey 
only may have done so prior to their follow-up diagnostic appointment.
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Non- adherence to a follow-up care plan following an abnormal Pap test may result 
from a complex combination of emotional, cultural, socioeconomic and logistical 
factors.20 In a systematic review of 26 studies that investigated risk factors for non- 
adherence, primary barriers included lesion severity and health beliefs.21 Women whose 
lesions were less severe were less likely to adhere to follow-up care plans.22,23 In a multi-
ethnic study, Nelson et al.24 identified fatalistic health beliefs and misconceptions about 
cancer, such as the need for Pap tests following abnormal bleeding only, as risk factors 
for non- adherence among Spanish- speaking Latinas and Asians. Once the investigators 
controlled for these factors, there was no association between race/ ethnicity and non- 
adherence. Two studies that did not control for health beliefs, reported that Latinas 
were less likely to adhere to follow-up recommendations than non- Hispanic White22 
and African American23 women. We did not examine fatalistic health beliefs in any of 
our formative research, but misconceptions about cancer were prevalent in our study 
(anecdotal evidence). Socioeconomic status may have accounted for some women’s 
failure to receive follow-up care, but self- pay women who qualified for the Texas Breast 
and Cervical Cancer Screening Program would have been covered by the program.
Lindau et al.25 identified physician estimates of low health literacy as a barrier to 
adherence to a care plan following an abnormal Pap test. Evaluations of printed HPV 
(n=21) and cervical cancer prevention (n=69) educational materials designed to enhance 
patient knowledge and awareness found that most materials had readability levels 
higher than 8th grade and low suitability.26– 28 Brandt et al.26 also identified poor HPV 
content for the majority of HPV educational materials; however, the brochure utilized 
in the present analysis was not included in the evaluation. HPV educational materials 
may be especially problematic for Latinas. Hunter29 examined written cervical cancer 
educational materials (n=22) utilized with first- generation Mexican women in Kansas 
City and found that language was problematic, in addition to readability, suitability, 
and content. Over half of the women in our study completed the interview in Spanish; 
although the HPV brochure was translated into Spanish it may not have been tailored 
to the cultural needs of these women.
Our study has limitations. We restricted our analysis to Latinas who had completed 
at least one follow-up survey, the response rate to our 12-month follow-up survey was 
low, self- reported receipt of follow-up care is prone to misclassification, and there was 
potential contamination across intervention groups. Although our restriction reduced 
our sample by 19%, we found similar results when we compared baseline characteristics 
of all 460 participants with the 373 women included in the present study. Our response 
rate for the 12-month follow-up survey of 55% was primarily due to the 43% of par-
ticipants who had not been followed a sufficient amount of time. The demographic and 
other baseline characteristics of women who were not followed a full year were similar 
to those of women who were followed for that period of time. The HPV knowledge, 
attitudes, and beliefs scales/ subscales were developed through formative research and 
were not quantitatively validated.
Self- reported participation in cancer screening has shown “dependable agreement” 
with provider report, medical records review, and health insurance claims data.30,31 We 
conducted a validation sub- study of self- reported diagnostic procedures at follow-up 
and calculated sensitivity and specificity using the medical record as the gold standard. 
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While repeat Pap test had the highest sensitivity (87.1), it had the lowest specificity 
(39.7). We found moderate sensitivity and specificity for colposcopy (sensitivity 58.1, 
specificity 65.0) and biopsy (sensitivity 76.5, specificity 72.4). Medical records were 
collected approximately 3 months following the diagnosis so participants who received 
follow-up care subsequent to that time were not captured in the medical record. This 
may help explain the low specificity for repeat Pap test, but not the moderate sensitivity 
and specificity for colposcopy and biopsy.
There was a potential contamination effect since the HPV brochure and other sources 
of information may have been available to women in the usual care arm. Some pro-
viders responded they used HPV patient educational materials from Krames, Planned 
Parenthood, CDC, American College of Obstetricians and Gynecologists, Merck, and 
county health departments. The majority of participating providers were not sure of 
the publisher of the HPV patient educational materials they used. As noted previously, 
each survey a woman completed could be considered an educational intervention even 
though the HPV brochure was distributed only at baseline.
Study strengths include the population, and the use of information collected from 
providers and medical records to aid in the interpretation of results. Latinas living on 
the Texas- Mexico border have a high prevalence of abnormal Pap tests making the 
present study one of the largest studies of this topic. Few studies of follow-up care 
among Latinas have utilized information from providers in conjunction with informa-
tion from patients. In addition, this is one of the first studies to determine the validity 
of reporting of follow-up care after abnormal Pap test conducted among Latinas that 
utilized medical records.
One of the possible explanations for the cervical cancer disparity among Latinas 
relative to other ethnic groups is the failure to follow the prescribed recommendation 
after an abnormal Pap test. Our findings suggest that although Latinas living on the 
Texas- Mexico border are aware that follow-up care is recommended they may not 
receive this care. Individual, family and medical care barriers to receipt of follow-up 
care may partially account for higher rates of cervical cancer mortality in this region.
This failure to receive follow-up care did not differ in women who received the 
brochure intervention or usual care, perhaps because the brochure’s readability, suit-
ability, HPV content and/or language were inappropriate for the population targeted, 
or because both groups of patients could be considered compliant since they were in 
the system and returning for counseling. A study of 44 low- income, high- risk HPV 
positive women found they preferred information written in an easily understood 
language, but their most trusted source of information was face- to-face with their 
health care provider.32 It is likely that to increase follow-up, these women may require 
more than educational materials. Other studies have shown that follow-up and time to 
follow-up improves with patient navigation.33 A study of obstetricians and gynecologists 
reported low physician adherence to current cervical cancer screening guidelines.34 
Multi- level intervention approaches that target provider communication, organization 
change (such as reminder systems) as well as patient education are likely needed35 to 
reduce the elevated cervical cancer mortality among Latinas living on the Texas- Mexico 
border.
In conclusion, although our study is somewhat dated, the problem of cervical can-
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cer incidence and mortality on the Texas- Mexico border persists evidenced by having 
among the highest rates in Texas.7 Additional research is needed to examine the role 
of health care access, lack of health care coverage, and other social and environmental 
factors such as abusive/ interfering partners and job and family responsibilities that 
may contribute to reduced participation in follow-up care.
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